CAT vs JANX · P/E 48, rev $37.96B vs rev $10.3M
Caterpillar Inc (CAT) versus Janux Therapeutics Inc (JANX) — a side-by-side from cached financials, not a winner call.
Caterpillar Inc (CAT) is a farm & heavy construction machinery company listed on NYSE. It is led by Jim Umpleby.
Janux Therapeutics Inc (JANX) is a biotechnology company listed on US.
Latest reported CAT revenue for 2026-06-30 was $37.96B. Net income was $6.14B. CAT currently screens at market cap $440.29B and trailing P/E 47.7.
Latest reported JANX revenue for 2026-06-30 was $10.3M. Net income was -$22.0M. JANX currently screens at market cap $1.49B.
CAT currently screens at market cap $440.29B and trailing P/E 47.7. JANX currently screens at market cap $1.49B.
Not investment advice. Open the CAT and JANX stock pages for the full models.
Not investment advice.